Please provide your email address to receive an email when new articles are posted on . Among pediatric patients in the Pediatric Pulmonary Hypertension Network, nearly half had group 3 disease, ...

Higher pulmonary resistance was associated with worse outcomes in pulmonary hypertension, while SGLT2 inhibitors may improve ...

Pulmonary arterial hypertension (PAH) is a type of high blood pressure in the arteries that go from your heart to your lungs. It happens when these arteries become narrow or blocked, making it harder ...

Pulmonary hypertension is high blood pressure in the arteries of your lungs. These arteries carry blood from the heart to the lungs and when the walls of the arteries get thick, it narrows the space ...

Patients who have heart failure with preserved ejection fraction (HFpEF) and high blood pressure in the lungs (pulmonary ...

Hydrogen sulfide can effectively reverse established hypoxia-induced PH and remodeling of pulmonary vascular structure in a rat model.

New data reported in a presentation at the American College of Rheumatology (ACR) annual meeting showed that tumor necrosis factor (TNF) receptor 1 (TNFR1) rather than TNFR2 is responsible for ...

A rare association exists between pulmonary hypertension (PH) and hematologic malignancies, particularly AML evolving from MPN. The case study involves a 32-year-old woman with JAK2 mutation-positive ...

Winrevair, also known as sotatercept-csrk, is a medicine used to treat pulmonary arterial hypertension (PAH), which causes high blood pressure in the arteries that go from your heart to your lungs.